Windward Bio
Phase 2Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with advanced immunological diseases.
Founded
2021
Focus
AntibodiesBiologics
About
Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with advanced immunological diseases.
Funding History
1Total raised: $5.5M
Seed$5.5MUndisclosedJun 15, 2022
Company Info
TypePrivate
Founded2021
LocationBasel, Switzerland
StagePhase 2
Contact
SIMILAR COMPANIES
3Brain
Pre-clinical · Zug
Baxiva
Pre-clinical · Zug
AC Bioscience
Pre-clinical · Lausanne
Abrinca Genomics
Pre-clinical · Zurich
AdipoGen
Pre-clinical · Liestal
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile